Exciting news in organ donation! A recent JAMA study reveals living kidney donation is safer than ever. This increased safety, attributed to newer surgical techniques, could boost living donation rates. With 90,000 people awaiting kidney transplants in the US, this news offers hope to patients and potential donors alike. While short-term risks have decreased, potential donors should still consider long-term factors. Nevertheless, this study marks a significant advancement in transplant medicine. #OrganDonation #KidneyTransplant #MedicalAdvancement https://ow.ly/j2Sf50TjmPn
Natera Organ Health
Biotechnology Research
Austin, TX 2,897 followers
Improving patient outcomes through an innovative platform for genetic testing in kidney health and organ transplantation
About us
Improving patient outcomes through an innovative platform for genetic testing in kidney health and organ transplantation. Follow us on Twitter: @NateraNeph
- Website
-
https://www.natera.com/organ-health
External link for Natera Organ Health
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Austin, TX
- Founded
- 2004
- Specialties
- transplant, kidney transplant, transplant rejection, cell-free DNA, and genetic testing
Updates
-
📅 Mark your calendar for Wednesday, September 25th. Join Natera and ISHLT - International Society for Heart and Lung Transplantation for this webinar on combining the quantity and fraction of dd-cfDNA in a single blood test to improve the accuracy of noninvasive rejection screening post organ transplantation. Register here: https://lnkd.in/eK8Wp-VD Prospera Heart now incorporates a second metric – the Donor Quantity Score (DQS) – which is the estimated quantity of cell-free DNA coming from the donated heart, and is independent of fluctuations in levels of total cell-free DNA. Learn how the addition of DQS significantly reduces the rate of false positive results and improves the accuracy of detecting both acute cellular rejection (ACR) and antibody mediated rejection (AMR). #Natera #OrganTransplant #ISHLT
This content isn’t available here
Access this content and more in the LinkedIn app
-
Inside the Proactive study | How Dr. Batarse diagnosed ABMR despite a negative biopsy from his routine Prospera protocol. In this episode, Dr. Rodolfo Batarse, transplant neurologist and President of Desert Kidney Care, describes: 🔬His experience diagnosing ABMR despite a negative biopsy 🥼His protocol as “proactive vigilance and maintenance with Prospera” 📊The ease of implementation of the test, with great patient satisfaction Desert Kidney Care (FKA Rodolfo R Batarse MD) https://ow.ly/IcH650SNfwp
How Dr. Batarse diagnosed ABMR despite a negative biopsy from his routine Prospera protocol
https://www.youtube.com/
-
The National Kidney Foundation (NKF) released a consensus statement recommending genetic testing for all categories of kidney diseases when a genetic cause is suspected. NKF joins KDIGO as the second medical society this year to recommend genetic testing for the majority of patients with kidney disease. We support this shift towards genetic testing in nephrology. Our Renasight kidney gene panel tests 385 genes associated with chronic kidney disease (CKD) to determine if there is a genetic cause for an individual’s kidney disease or if there is an increased hereditary risk due to family history. Findings from our RenaCARE study, a landmark, real-world, prospective study of comprehensive genetic testing in >1,600 patients with CKD showed that 1 in 5 patients with CKD had a positive genetic finding. Read more about this new guidance in Medscape below. https://ow.ly/CMYR50SXJtL #Nephrology #GeneticTesting #KidneyDisease #CKD #Natera
New Guidance on Genetic Testing for Kidney Disease
medscape.com
-
PODCAST 🎧 ProActive Study Investigator, Dr. Matthew Cooper, discusses his perspective on the registry’s first publication findings and its impact on patient education around why monitoring matters. Discover the remarkable potential of cell-free DNA testing to predict and prevent organ rejection, reducing the need for biopsies and enhancing the longevity of transplanted kidneys. Kent’s personal insights and Dr. Cooper’s expertise combine to offer an informative and inspiring session for patients and medical professionals alike. Listen to the full episode 👇 https://ow.ly/sQbO50STl4K #Natera #ctDNA #Kidney #Transplant
Kent's Kidney Stories
natera.com
-
[Inside the ProActive Study Podcast] How Dr. Sanjiv Anand’s experience in the ProActive Study informed his center’s Prospera surveillance protocol. In this episode, Dr. Sanjiv Anand, medical director of the Living Donor Transplant Program at Intermountain Health, share his insights on: 🩺 Protocol for patients 13-months post-transplant 🧬 Use of cfDNA as an “immune dial” 📑 Case examples where close monitoring guided care decisions to provide peace of mind to his patients https://ow.ly/Cgp750SRb1x #Natera #KidneyTransplant
How Dr. Anand’s experience in ProActive Study informed his center’s Prospera surveillance protocol
https://www.youtube.com/
-
At #ATC2024Philly, we unveiled three new presentations from the ProActive Study, the largest prospective donor-derived cell-free DNA (dd-cfDNA) study in #KidneyTransplant recipients. Missed it? Click below for a replay 👇 https://ow.ly/c7BX50SMBwS #Natera #MedicalResearch
-
-
[Inside the ProActive Study Podcast] 🎧 How Dr. German Lozano-Guzman, Medical Director of the Kidney Transplant Program at Children’s Hospital in Phoenix, introduced a cfDNA surveillance protocol to his pediatric transplant program using #Natera's Prospera test. https://ow.ly/VXrN50SK5x1 Phoenix Children's
-
-
We are excited to share that over 100,000 patients have been tested with Natera's Renasight test! In 2020, we developed and launched Renasight, which can help determine if there is a genetic cause for an individual’s chronic kidney disease (CKD) or if there is an increased hereditary risk due to family history. Having this information is incredibly valuable for disease management of CKD, which affects more than 35 million people in the US. Since launching Renasight, several publications along with societal guidelines like KDIGO, have supported genetic testing for the majority of patients affected by CKD. In fact, our recent publication on the RenaCARE study in the Journal of the American Society of Nephrology shows that 1 in 5 patients with CKD had a positive genetic finding. We are proud to support the kidney care community and look forward to continuing to improve kidney disease diagnoses and help optimize patient care. https://ow.ly/v1O450SK6WS #Natera #KidneyDisease
-
-
Knowing the cause of kidney disease is important to help support treatment and lifestyle decisions, guide family planning and protect the overall health of the person living with kidney disease. Up to 15% of people with kidney disease do not know the cause of their disease and ~1 in 10 people with kidney disease have a genetic diagnosis. Thank you, Suni and American Kidney Fund for helping raise awareness. 👏
The American Kidney Fund is thrilled to announce our partnership with reigning All-Around Gymnastics Champion Suni Lee for our Know Your Kidneys initiative. Suni made an incredible comeback in her gymnastics career after her kidney disease diagnosis, and will compete in Paris later this month! In her partnership with AKF, she will share her kidney disease experience and promote the #KnowYourCause pathway of our #KnowYourKidneys program, sharing resources that can help those seeking a diagnosis. To learn more about this partnership, visit our website: https://bit.ly/3Y0PEVr
-